Other Viruses Citation List: March 16 - March 29, 2012

Hepatitis B virus

1. Antiviral Activity of FNC, 2'-Deoxy-2'-beta-fluoro-4'-azidocytidine, against Human and Duck HBV Replication. Zheng, L., Q. Wang, X. Yang, X. Guo, L. Chen, L. Tao, L. Dong, Y. Li, H. An, X. Yu, and J. Chang, Antiviral Therapy, 2012. [Epub ahead of print]; PMID[22452880].
[PubMed]. OV_0316-032912.

2. Synthesis and Antiviral Activity of 6-Deoxycyclopropavir, a New Prodrug of Cyclopropavir. Li, C., D.C. Quenelle, M.N. Prichard, J.C. Drach, and J. Zemlicka, Bioorganic & Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22417649].
[PubMed]. OV_0316-032912.

Hepatitis C Virus

3. Synthesis and Antiviral Activity of a Series of 1'-Substituted 4-aza-7,9-dideazaadenosine C-nucleosides. Cho, A., O.L. Saunders, T. Butler, L. Zhang, J. Xu, J.E. Vela, J.Y. Feng, A.S. Ray, and C.U. Kim, Bioorganic & Medicinal Chemistry Letters, 2012. [Epub ahead of print]; PMID[22446091].
[PubMed]. OV_0316-032912.

4. Discovery of Flavonoid Derivatives as anti-HCV Agents via Pharmacophore Search Combining Molecular Docking Strategy. Liu, M.M., L. Zhou, P.L. He, Y.N. Zhang, J.Y. Zhou, Q. Shen, X.W. Chen, J.P. Zuo, W. Li, and D.Y. Ye, European Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22445328].
[PubMed]. OV_0316-032912.

5. A 2'-Deoxy-2'-fluoro-2'-C-methyl uridine cyclopentyl carbocyclic Analog and Its Phosphoramidate Prodrug as Inhibitors of HCV NS5B Polymerase. Liu, J., J. Du, P. Wang, D. Nagarathnam, C.L. Espiritu, H. Bao, E. Murakami, P.A. Furman, and M.J. Sofia, Nucleosides, Nucleotides & Nucleic acids, 2012. 31(4): p. 277-285; PMID[22444190].
[PubMed]. OV_0316-032912.

6. Genotype and Subtype Profiling of PSI-7977 as a Nucleotide Inhibitor of Hepatitis C Virus. Lam, A.M., C. Espiritu, S. Bansal, H.M. Micolochick Steuer, C. Niu, V. Zennou, M. Keilman, Y. Zhu, S. Lan, M.J. Otto, and P.A. Furman, Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22430955].
[PubMed]. OV_0316-032912.

7. Inhibition of Hepatitis C Virus NS5A by Fluoro-olefin Based Gamma-turn Mimetics. Chang, W., R.T. Mosley, S. Bansal, M. Keilman, A.M. Lam, P.A. Furman, M.J. Otto, and M.J. Sofia, Bioorganic & Medicinal Chemistry Letters, 2012. [Epub ahead of print]; PMID[22425564].
[PubMed]. OV_0316-032912.

8. Discovery of Novel P3-oxo Inhibitor of Hepatitis C Virus NS3/4A Serine Protease. Duan, M., W. Kazmierski, R. Crosby, M. Gartland, J. Ji, M. Tallant, A. Wang, R. Hamatake, L. Wright, M. Wu, Y.K. Zhang, C.Z. Ding, X. Li, Y. Liu, S. Zhang, Y. Zhou, J.J. Plattner, and S.J. Baker, Bioorganic & Medicinal Chemistry Letters, 2012. [Epub ahead of print]; PMID[22425454].
[PubMed]. OV_0316-032912.

9. Synthesis and SAR Studies of Novel Heteroaryl Fused Tetracyclic indole-diamide Compounds: Potent Allosteric Inhibitors of the Hepatitis C Virus NS5B Polymerase. Ding, M., F. He, T.W. Hudyma, X. Zheng, M.A. Poss, J.F. Kadow, B.R. Beno, K.L. Rigat, Y.K. Wang, R.A. Fridell, J.A. Lemm, D. Qiu, M. Liu, S. Voss, L.A. Pelosi, S.B. Roberts, M. Gao, J. Knipe, and R.G. Gentles, Bioorganic & Medicinal Chemistry Letters, 2012. [Epub ahead of print]; PMID[22424979].
[PubMed]. OV_0316-032912.

HSV-1

10. Synthesis, Molecular Conformation and Activity against Herpes Simplex Virus of (E)-5-(2-Bromovinyl)-2'-deoxycytidine Analogs. Zoghaib, W.M., S. Mannala, V.S. Gupta, and G. Tourigny, Nucleosides, Nucleotides & Nucleic acids, 2012. 31(4): p. 364-376; PMID[22444197].
[PubMed]. OV_0316-032912.

11. Biological Activities of Purified Marennine, the Blue Pigment Responsible for the Greening of Oysters. Gastineau, R., J.B. Pouvreau, C. Hellio, M. Morancais, J. Fleurence, P. Gaudin, N. Bourgougnon, and J.L. Mouget, Journal of Agricultural and Food Chemistry, 2012. [Epub ahead of print]; PMID[22423636].
[PubMed]. OV_0316-032912.

Citations from the ISI Web of Knowledge Listings for O.V.

12. Catalytic Metallodrugs Targeting HCV IRES RNA. Bradford, S. and J.A. Cowan, Chemical Communications, 2012. 48(25): p. 3118-3120; ISI[000300782600024].
[WOS]. OV_0316-032912.

13. Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel in Vitro Pharmacodynamic System. Brown, A.N., J.J. McSharry, J.R. Adams, R. Kulawy, R.J.O. Barnard, W. Newhard, A. Corbin, D.J. Hazuda, A. Louie, and G.L. Drusano, Antimicrobial Agents and Chemotherapy, 2012. 56(3): p. 1170-1181; ISI[000300623300004].
[WOS]. OV_0316-032912.

14. Hepatitis C Virus Replication-Specific Inhibition of MicroRNA Activity with Self-cleavable Allosteric Ribozyme. Lee, C.H., J.H. Kim, H.W. Kim, H. Myung, and S.W. Lee, Nucleic Acid Therapeutics, 2012. 22(1): p. 17-29; ISI[000300632900003].
[WOS]. OV_0316-032912.

15. Lignans from the Heartwood of Streblus asper and Their Inhibiting Activities to Hepatitis B Virus. Li, L.Q., J. Li, Y. Huang, Q. Wu, S.P. Deng, X.J. Su, R.Y. Yang, J.G. Huang, Z.Z. Chen, and S. Li, Fitoterapia, 2012. 83(2): p. 303-309; ISI[000300817000008].
[WOS]. OV_0316-032912.

16. Safety, Pharmacokinetics (pk), and Antiviral Activity of RG7348, a Novel Hepdirect (TM) Liver-targeted Double Prodrug Hepatitis C Virus (HCV) Nucleotide Polmerase Inhibitor. Nieforth, K.A., P.N. Morcos, L. Chang, B. Davies, R. Li, and P.F. Smith, Clinical Pharmacology and Therapeutics, 2012. 91: p. S99-S100; ISI[000300524900260].
[WOS]. OV_0316-032912.